Cytosorbents (CTSO) Shares Outstanding (2010 - 2026)

Cytosorbents (CTSO) has 17 years of Shares Outstanding data on file, last reported at $62.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding changed 0.33% year-over-year to $62.7 million; the trailing twelve-month figure through Mar 2026 stood at $62.7 million (changed 0.33% YoY), and the FY2025 full-year result was $62.8 million, up 14.54% from the prior year.
• Shares Outstanding for Q1 2026 stood at $62.7 million, roughly flat from $62.8 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $62.8 million in Q4 2025 and bottomed at $43.5 million in Q1 2022.
• The 5-year median for Shares Outstanding is $54.3 million (2024), against an average of $52.5 million.
• The widest annual swing landed in 2023, when Shares Outstanding increased 24.3%; it then increased 0.33% in 2026.
• A 5-year view of Shares Outstanding shows it stood at $43.6 million in 2022, then increased by 24.3% to $54.2 million in 2023, then rose by 1.09% to $54.8 million in 2024, then climbed by 14.54% to $62.8 million in 2025, then decreased by 0.11% to $62.7 million in 2026.
• The last three Shares Outstanding figures came in at $62.7 million (Q1 2026), $62.8 million (Q4 2025), and $62.8 million (Q3 2025), per Business Quant data.

Peer Comparison